Monitor for future 8-K or 6-K filings announcing actual offering terms. Shelf registrations often precede at-the-market (ATM) offerings or follow-ons, which could pressure shares if significantly dilutive. Given IMA's small $53M market cap, even a modest offering could materially impact the stock.
Price Chart
Executive Summary
ImageneBio, Inc. (IMA) has an effective SEC registration (Form S-3) allowing it to sell unspecified securities. This is a shelf registration, not an IPO, meaning the company can now issue shares at any time, creating potential dilution overhang. No offering size, pricing, or use of proceeds details are disclosed in this filing.
Key Facts
- ImageneBio, Inc. (IMA) has received SEC effectiveness for registration statement 333-290108.
- This is a shelf registration (S-3), not an IPO, enabling the company to sell securities from time to time.
- No specific offering size, share count, price, or timing is disclosed in the filing.
- The effectiveness date was April 3, 2026, with the filing updated on April 6, 2026.
- The company was formerly known as Ikena Oncology, Inc. (name changed December 8, 2020).
Financial Impact
Undisclosed — potential future dilution depending on offering size and price
Risk Factors
- Future dilution risk if the company issues equity under this shelf
- Lack of transparency on offering size or timing creates uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001080 |
| Document: 9999999995-26-001080-index.html | 9999999995-26-001080 |
| Document: 9999999995-26-001080.txt | 9999999995-26-001080 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 7, 2026 8w ago | EFFECT | $5.69 $4.85 | ▲ +14.76% | ▲ +14.37% | $4.60 (+19.16%) |
Jun 26, 2026 14w ago | 8-K | $6.07 $5.59 | ▼ −7.91% | ▼ −7.63% | $4.60 (−24.22%) |
Apr 30, 2026 22w ago | DEFA14A | $5.66 $5.47 | ▼ −3.36% | ▼ −8.62% | $4.60 (−18.73%) |
Apr 13, 2026 24w ago | 8-K | $6.05 $5.61 | ▲ +7.27% | ▲ +15.00% | $4.60 (+23.97%) |
Apr 13, 2026 24w ago | Press Release | $6.05 $5.61 | ▲ +7.27% | ▲ +15.00% | $4.60 (+23.97%) |
Apr 6, 2026 25w ago | EFFECT | $4.55 $5.72 | ▲ +25.60% | ▲ +16.62% | $4.60 (+1.10%) |
Mar 17, 2026 28w ago | Press Release | $5.83 $5.78 | ▼ −0.77% | ▼ −6.82% | $4.60 (−21.03%) |
Mar 10, 2026 29w ago | Press Release | $6.07 $4.57 | ▼ −24.71% | ▼ −24.56% | $4.60 (−24.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access